hiv-1 specific car-t cells
Cell therapyexperimental
Clinical trial activity
5 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 22, 2017 (NCT03240328)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, passive
Human immunodeficiency virus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06880380 | Phase 1 | Mar 7, 2025 | China Academy of Chinese Medical Sciences, Tsinghua University |
| NCT03881774 | Phase 1 | Feb 27, 2019 | Henan Hualong Biotechnology Company, Henan Medical University |
| NCT03434769 | Phase 1 | May 2, 2018 | Case Western Reserve University |
| NCT03240328 | Phase 1 | Aug 22, 2017 | Guangzhou Medical University, Sun Yat-Sen University |
| NCT04008524 | N/A | — | Chinese Academy of Medical Sciences, Juventas Therapeutics, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Case Western Reserve University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | — |
| Guangzhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Henan Hualong Biotechnology Company | Government | 1 | 0 | 1 | 2019 |
| Henan Medical University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Juventas Therapeutics, Inc. | For profit | 1 | 0 | 1 | — |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Tsinghua University | Academic/Hospital | 1 | 0 | 1 | 2025 |
9 organizations
Page 1 / 1